FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← NAGE · Niagen Bioscience, Inc.
DEFA14AThe Ballot

Niagen Bioscience, Inc. files DEFA14A

Filed Apr 25, 2024 · 2y ago · Accession 0001628280-24-018142

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Niagen Bioscience, Inc.
Ticker
NAGE
CIK
1386570
Form type
DEFA14A
Filing date
Apr 25, 2024
Report date
—
Document
defa14a.htm
Size
485 KB

More from NAGE

8-KShareholder VoteJun 29, 20268-KResults of Operations · Reg FD DisclosureMay 6, 202610-QThe RecordMay 6, 2026DEF 14AThe BallotApr 29, 2026DEFA14AThe BallotApr 29, 20268-KCompany UpdateMar 19, 2026